Supplementary Information

Fig. S12
Reduction of PHD2.1/2 imine adducts. PHD2 (20 µM) was incubated (1 h, 37 °C) with equimolar Fe(II) and aldehyde 1 (or 2) in buffer (15 mM ammonium acetate, pH 7.5) to enable formation of the imine adduct. The modified enzyme was subsequently immobilised on a C18 column, and the imine reduced by eluting (5 mL, 1 mL min -1 ) with NaBH 3 CN (30 mM) in buffer (50 mM sodium phosphate, pH 7.5). immunoblotting. The inhibitor FG4592 was used as a control. 
Denaturing mass spectrometry
Intact protein masses were obtaine by liquid chromatography-mass spectrometry (LC-MS) using a Waters LCT premier XE time-of-flight mass spectrometer interfaced with a Waters 1525u HPLC pump and Waters 2777 autosampler.
The protein sample (10 µM, 5 µl) was injected onto a Chromolith FastGradient RP-18 2x50mm Monolithic reverse phase HPLC column and eluted at 0.4 ml.min -1 using a gradient system from Solvent A (water, 0. mM NaCl). In the positive control no inhibitor was added. The resultant mixture was incubated at 37 °C and samples (3 µM) were taken at regular intervals and quenched by addition of 1% (v/v) aqueous formic acid (3 µM). Samples were analysed using a MALDI micro MX mass spectrometer (Waters) in the reflectron positive ion mode. Data were processed using MassLynx v4.0. The yield of crosslinking was determined by comparison of the signal intensities for crosslinked and unmodified protein.
Analysis of protein activity by peptide turnover assay using the AlphaScreen™ 3
The assay consisted of three parts: pre-incubation with inhibitor, the PHD2 hydroxylation reaction, and incubation with the AlphaScreen™ bead mix. The assay was carried out in 384-well white ProxiPlates (PerkinElmer). The reaction was performed in buffer (50 mM HEPES, pH 7.5, 0.01% Tween-20 and 0.1% BSA) in a final volume of 10 μL at room temperature. The enzyme mix (5 nM PHD2 (residues 181-426), 20
μM Fe(II) and 200 μM ascorbate) was incubated with the inhibitor (1 min, 20 min or 1 h) prior to addition to the peptide mix (60 nM biotinylated CODD peptide-HIF-1α 556-574 and 2 μM 2OG). The resulting solution was incubated for 10 min at room temperature before the hydroxylation reaction was quenched by addition of EDTA (5 μL, 30 mM). 5 μL of pre-incubated donor-acceptor bead mix (AlphaScreen streptavidin-conjugated donor and ProteinA-conjugated acceptor beads; PerkinElmer) with HIF-1α hydroxy-Pro546 antibody (Cell Signalling) was added to the reaction mixture followed by incubation for 1 h in the dark at room temperature.
The luminescence signal was acquired with an Envision (Perkin Elmer) plate reader.
of 10 min. The labelling reagent was removed by flushing with solvent A (2 mL), and the protein was eluted with solvent B (1 mL). The solvent was removed by vacuum centrifuge, and the protein reconstituted in 8 M urea prior to digestion using trypsin.
Solvent A -0.6% acetic acid; Solvent B -0.6% acetic acid and 80% acetonitrile.
Protein digestion and LC-MS/MS 5
Protein samples (50 µL) were denatured by addition of 8 M urea (150 µl) and reduced with DTT (2 µl, 200 mM) at 56 °C for 25 min. The samples were cooled to room temperature and the cysteinyl residues were alkylated by addition of iodoacetamide (4 µl, 36 mg/ml) and incubation in the dark (20 min, room temperature). Dithiothreoitol (2 µl, 200 mM) was added to neutralise the iodoacetamide, and the samples were diluted with buffer (600 µl, 50 mM ammonium bicarbonate), before addition of trypsin (1:50, w/w). The resulting mixture was incubated for 16 h at 37°C and then quenched by addition of formic acid (10 uL).
Digests were analysed using an Orbitrap Elite™ machine (Thermo Fisher Scientific™, DE) respectively. The 20 most intense peaks in the full MS scan were selected for fragmentation using either HCD, CID, or using a data-dependent decision tree (DDDT) to select between CID and ETD. In DDDT mode, ETD fragmentation was used for charge states 3, 4 and 5 with m/z less than 750 and for all charge states greater than 5. CID fragmentation was used for all other peptides. Dynamic exclusion was enabled (exclusion list size 75, exclusion duration 5 s).
The raw data files generated were processed using MaxQuant software (Version 1.4.1.2), integrated with the Andromeda search engine as described elsewhere. Data were searched against PHD2 protein sequence, as well as list of common contaminants defined by Andromeda. Protein and PSM false discovery rates (FDR) were set at 0.01. The minimum number of quantified peptides required per protein was set to 2. The maximum number of missed cleavages was set to be 2. Oxidation (M) and acetylation (N-term) were allowed as a variable modifications and carbamidomethylation (C) was used as a fixed modification. The covalent inhibitor modifications were created in Andromeda and allowed to occur on any nucleophilic residue. All assignments of modifications were validated by manual inspection of spectra. 
Photoreaction studies
Strain promoted 'click' reaction
PHD2 (20 µM), Fe(II) (20 µM) and 6 (20 µM) in buffer (15 mM ammonium acetate, pH 7.5) were incubated for 4 h at 37 °C. Bicyclo[6.1.0]non-4-yn-9-ylmethyl (2-(2-(2-(6-oxo-6-(2-oxohexahydro-1H-thieno [3,4- d]imidazol-4-yl)hexanamido)ethoxy)ethoxy)ethyl)carbamate 7 (100 µM) was added and the resultant solution incubated for 1 h at 37 °C. Products were analysed by denaturing liquid chromatography-mass spectrometry.
Data were processed with MassLynx ™ v4.0 (Waters) and protein peaks were deconvoluted using the Maximum Entropy method (MaxEnt1). The PCR reactions yielded product mixtures containing mutated plasmids and parental (non-mutated) dsDNA templates. It was necessary to remove the non-modified templates before transformation since they both contain the same antibiotic resistance gene. This was achieved by digesting the PCR products with the DpnI restriction enzyme (Stratagene Instruction Manual #200518). Since DpnI works on methylated/hemimethylated DNAs, the plasmid DNA templates were isolated from dam + E. coli strain so that the parent DNA could be digested. DpnI (1 μL) was added to the PCR products, gently mixed and centrifuged for 1 minute before being digested for 3 hours at 37ºC. For tranformation, an aliquot of XL10-Gold competent cells (50 μL) was transferrd to a 1.5 mL sterile Eppendorf vial and the plasmid/PCR product (1 μL) was added with gentle mixing. Cells were treated with β-mercaptoethanol (2 μL) to enhance transformation efficiency.
Preparation of PHD2 and variants
The transformation mixture was chilled on ice for 30 minutes, followed by a heat shock for 30 seconds at 42ºC to induce DNA uptake. The cells were incubated at 37ºC for one hour with 200 μl 2× TY medium and placed on LB-agar plates containing kanamycin (30 μg/mL). Finally, the plates were incubated at 37ºC. A single colony resulting from transformation was inoculated into 10 ml 2× TY medium containing kanamycin.
The starter culture was grown overnight at 37ºC with shaking at 220 rpm. Plasmid DNA was purified from the culture using the Qiagen Miniprep Kit following the manufacturer's protocol. All plasmids were verified by DNA sequencing at the Geneservice Ltd., Department of Biochemistry, University of Oxford. The results were compared to wildtype sequence to ensure the amplified insert or the mutated plasmid sequence was as desired and in the correct reading frame.
Recombinant protein production 6
A single colony was inoculated into 100 mL 2× TY media (overnight, 37ºC, shaken at 200 rpm) containing kanamycin (30 μg/mL). Then 7 ml of overnight starter culture was used to inoculate 2 L flasks containing 600 mL of 2× TY growth media with kanamycin (30 μg/mL). The flasks were incubated at 37ºC until the A 600 reached the range of 0.6-0.8, after which IPTG (600 μL, 0.5 mM) was added and growth was continued for an optimum incubation period (3-4 hours). Cells were harvested by centrifugation (9,000 rpm, 4ºC, 15 minutes) and the wet pellets were stored at -80ºC for protein purification. The frozen cell pellets were resuspended in 5 mL lysis buffer (see below) per gram of wet cell pellet. The cell suspension was then lysed by sonication on ice (4 × 45 sec sonication, 45 sec rest in between), using a SONICS VibraCell sonicator 150 sonicator, with a microtip at 60% amplitude. DNAse I (0.02 mg/mL) and MgCl 2 (5 mM) were added to the lysate to digest chromosomal DNA. The solution was left on ice for 20 minutes and then centrifuged (9,000 rpm, 20 minutes, 4ºC). The supernatant was retained for the assessment of protein levels or for the purification of soluble proteins. Enzymes were purified at 4ºC using an AKTA Fast Protein Liquid Chromatography (FPLC) System, Amersham Pharmacia Biotech (Liquid Chromatography Controller UPC-900 equipped with a high precision P-920 pump). The FPLC system was controlled from a PC running UNICORN v. 4.00. All buffers were freshly prepared with ddH 2 O and filtered through 0.2 μm Millipore filter before use. The cell extracts were prepared in Protino Ni-TED lysis-equilibration-wash (LWE) buffer (0.5 mM NaCl, 20 mM Tris•HCl, pH 7.5).
The crude cell lysate was filtered through a Millipore 0.45 μm filter before application on a TED (Triscarboxymethyl ethylene diamine) column. The cleared lysates were then loaded onto a column preequilibrated with 10× column volume LEW buffer (1 CV = ~ 10 mL), followed by another 10 CV column wash. Protein was finally eluted with ~ 2 CV of elution buffer (0.5 mM NaCl, 0.5 mM imidazole, 20 mM Tris•HCl, pH 7.5). This procedure yielded His 6 -tagged proteins of > 90% purity by SDS-PAGE. The protein was concentrated by ultrafiltration (10 kDa MW cut-off, Amicon ultra-15, Millipore) and subjected to thrombin cleavage. High grade thrombin (Novagen) was used to remove the His 6 -tag from the N-terminus of a fusion protein according to the standard protocol: an accurate amount of thrombin (1 U per mg of protein) plus thrombin cleavage buffer were added to the protein solution as per the manufacturer's instructions. The thrombin-protein mixture was incubated at 4ºC overnight and then resolved by size exclusion chromatography. A Superdex S75, 300 mL (Pharmacia) column was fixed to the Akta FPLC and equilibrated with 1 CV of water and 2 CV of buffer (100 mM Tris•HCl, 100 mM NaCl, pH 7.5) at a flow rate of 2 mL/min.
The proteins were concentrated to around 2 mL using an Amicon ultra-15, Millipore centrifugal filter membrane, and loaded onto the column using a 2mL/ 10mL loop at 0.5 mL/min. After loading of proteins, the flow rate was increased to 2 mL/min with the UV baseline corrected to zero. The protein fractions were collected by an automatic fraction collector when the UV peak level rose above 25 mAU, in typical fractions of 5 mL. The eluted fractions were analysed for purity by SDS-PAGE. Those fractions containg pure protein were pooled and buffer exchanged into 50 mM Tris•HCl pH 7.5 using a PD-10 desalting column (Amersham Biosciences) and stored at -80ºC.
Synthesis
All chemicals, reagents, and solvents were from Sigma-Aldrich (Dorset, UK) and used without further purification. HPLC grade solvents were used for reactions, chromatography, and work-ups. Aqueous solutions were made using de-ionized water. Thin layer chromatography (TLC) was carried out using Merck 
2-(5-Formyl-2-hydroxybenzamido)acetic acid (S1)
A solution of S1x (140 mg, 0.56 mmol) in 1N NaOH (1.7 mL, 1.7 mmol) was stirred under Ar at room temperature for 2 hours. Then it was acidified with 6N HCl to pH 2 and extracted with EtOAc (3 × 30 mL), dried over MgSO 4 and evaporated to afford 122 mg (90%) of S1 as a white solid. 
3-Acetyl-2-hydroxy-5-methylbenzoic acid (S3x)
S3x was prepared following the reported procedure. 
2-(3-Acetyl-2-hydroxy-5-methylbenzamido)acetic acid (S3)
A solution of S3y (112 mg, 0.4 mmol) in 1N NaOH (1. 
Methyl 6-(formyl)pyridine-2-carboxylate (S4z)
To a solution of compound S4y (589 mg, 3.52 mmol) in CHCl 3 (25 mL) was added manganese dioxide (6.00 g, 69 mmol) and the mixture was heated to reflux for 5 hrs. The reaction mixture was then cooled down and filtered through a pad of silica gel, washed with EtOAc and evaporated affording S4z as a white solid (212 mg, 36%). 
6-Formylpyridine-2-carboxylic acid (S4w)
To a solution of compound S4z (101 mg, 0.61 mmol) in THF:H 2 O 1:1 (8 mL) was added 1M NaOH (5 mL) and the mixture was stirred for 30 min at room temperature under Ar.
Then THF was evaporated, the aqeuous layer acidified with 1M HCl (6 mL 
tert-Butyl 2-(6-formylpicolinamido)acetate (S4q)
To a solution of acid S4w (227 mg, 1. 
2-(6-Formylpicolinamido)acetic acid (S4)
To a stirred solution of S4q (110 mg, 0.42 mmol) in CH 2 Cl 2 (5 mL) at 0ºC was added CF 3 COOH (0.8 mL). The reaction mixture was stirred at room temperature for 7 hours, then solvent was evaporated and the residue then coevaporated with 
3-(tert-Butoxycarbonylamino)-2-hydroxybenzoic acid (3x)
To an ice-cooled solution of 3-aminosalicylic acid (765 mg, 5.0 mmol) in dioxane/water (14 mL/7 mL) were added Et 3 N (1.05 mL, 7.5 mmol) and di-tert-butyl dicarbonate (1.64 g, 7.5 mmol). The resulting mixture was then stirred for 24 hours at room temperature. The solvent was then removed under reduced pressure and HCl and dried over MgSO 4 . The crude product was purified by column chromatography (PE : EA 9:1 to 7:3) to afford 1.02 g (69%) of 3y as a white solid. 
2-(3-Amino-2-hydroxybenzamido)acetic acid (3z)
To a stirred solution of 3y (831 mg, 2.27 mmol) in CH 2 Cl 2 (15 mL) at 0ºC was added CF 3 COOH (2.5 mL). The reaction mixture was stirred at room temperature for 8 hours, then solvent was evaporated and the residue then coevaporated with 
3-Allyl-2-hydroxybenzoic acid (4z)
A stirred solution of 4y (768 mg, 4.0 mmol) in 1N NaOH (12.0 mL, 12.0 mmol) was heated at 50ºC for 2 hours under Ar. Then it was cooled to room temperature, acidified with 6N 
2-(3-Allyl-2-hydroxybenzamido)acetic acid (4)
To a stirred solution of 4w (460 mg, 1.75 mmol) in MeOH (3 mL) was added a solution of 1N NaOH (5.25 mL, 5.25 mmol) 
2-hydroxy-3-((O-methylglycine)-N-tertbutyl-benzocarbamate (6x)
To a solution of 3-(terbutoxycarbonyl) amino salicylic acid (506 mg, 2.00 mmol, 
2-hydroxy-3-((2-methoxy-2-oxoethyl)carbamoyl)benzenaminium 2,2,2-trifluoroacetate (6y)
To a yellow to orange solution of 6x (275 
2-hydroxy-3-((O-methylglycine)-N-benzoacrylamide (6)
A suspension of 6y (50 mg, 0.148 mmol, 1.0 equiv.) in CH 2 Cl 2 (4 mL, anhydrous) was cooled down to 0 °C while mechanically stirred for 10 min followed by dropwise addition of Et 3 N (22.8 μL, 0.163 mmol, 1.1 equiv). After 10 min, acyloyl chloride (18 μL, 0.222 mmol, 1.5 equiv) was added dropwise maintaining set conditions. The mixture was allowed to gradually warm up to room temperature, stirred for 2 hours and the crude was extracted from a 1 N HCl solution (15 mL), 3x 3, 169.8, 163.6, 152.0, 131.8, 127.3, 127.0, 126.2, 122.2, 118.0, 113.7, 51.2, 41 .0.
5-Bromo-2-hydroxy-3-nitrobenzoic acid (7x)
To a suspension of 5-bromosalicylic acid (23 g, 105 mmol) in concentrated sulfuric acid (70 ml) at 0°C, a mixture of nitric acid (6.6 ml) and conc. sulfuric acid (15.4 ml) was added dropwise whilst maintaining a reaction temperature of < 10°C. The reaction was stirred on ice for 1 hour before the ice bath was removed and the reaction stirred at room temperature for 3 hours at which point the reaction was observed to be complete by LCMS. The resulting mixture was decanted into a conical flask containing crushed ice, which gave a bright yellow precipitate which was collected by büchner filtration, washed with cold water and dried to leave a yellow solid. placed under an atmosphere of N 2 before being heated to 100°C with stirring using a microwave reactor, until complete consumption of the starting material was observed by LCMS (~ 45 mins).
The reaction was cooled to room temperature before being quenched with 1.0M HCl (aq) (~ 10 ml). The resulting suspension was passed through a short pad of silica gel and the filtrate was extracted with EtOAc (3 x 20 ml). The organic layers were collected, dried over anhydrous MgSO 4 , filtered and concentrated before being purified by flash column chromatography (99:1, EtOAc/AcOH 9, 125.3, 129.1, 137.2, 138.6, 152.7, 169.8 ppm. FT-IR ν max (neat) 3362, 3016, 2970 , 2497 , 1738 , 1532 , 1448 , 1365 , 1229 , 1216 , 1168 5, 40.1, 62.5, 120.4, 120.7, 124.5, 126.2, 132.9, 152.3, 167.5, 170.9 ppm. FT-IR ν max (film) 3410, 2940, 2110, 1742, 1650, 1583, 1535, 1470, 1377, 1325, 1210, 838 1 mmol) in distilled water (10.6 ml) was added dropwise. After 15 minutes the reaction was observed to be complete by LCMS and the reaction was decanted into a saturated brine solution. The mixture was extracted with EtOAc (5 x 30 ml) and the organic fractions collected, dried over anhydrous Na 2 SO 4 , filtered and concentrated to give amine (7wa) as a clear oil (100mg, 0.40 mmol, 56% yield), which was used without further purification for the next step.
Part vi): (3-amino-5-azido-2-hydroxybenzoyl)glycine (7wa) (100 mg, 0.40 mmol) was suspended in water (2 ml) and cooled with an ice bath. To this suspension was added 1.0M NaOH (aq) (400 μL) and acrolyl chloride (159 μL, 1.96 mmol). The mixture was then stirred for 1 hour after which a beige precipitate was observed to form which was isolated by Büchner filtration, dried over 48 hrs in a vacuum to give the product 7 as a beige solid (55 mg, 0.18 mmol, 25% yield over two steps). ppm.
13
C NMR (101 MHz, CD 3 OD) δ 41. 8, 113.1, 115.9, 116.9, 128.6, 129.9, 132.0, 132.1, 150.3, 166.4, 171.2, 172.8 ppm. FT-IR ν max (film) 2928 , 2496 , 2115 , 1728 , 1643 , 1595 , 1538 , 1475 , 1447 , 1247 
